[HTML][HTML] Comprehensive molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma
JA Nakauma-González, M Rijnders, J van Riet… - European urology, 2022 - Elsevier
Recent molecular characterization of primary urothelial carcinoma (UC) may guide future
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
JA Nakauma-González, M Rijnders… - European …, 2022 - pubmed.ncbi.nlm.nih.gov
Recent molecular characterization of primary urothelial carcinoma (UC) may guide future
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
JA Nakauma-González… - European …, 2022 - researchinformation.amsterdamumc …
Recent molecular characterization of primary urothelial carcinoma (UC) may guide future
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
JA Nakauma-González, J Voortman… - European …, 2022 - inrepo02.dkfz.de
Recent molecular characterization of primary urothelial carcinoma (UC) may guidefuture
clinical decision-making. For metastatic UC (mUC), a comprehensive …
clinical decision-making. For metastatic UC (mUC), a comprehensive …
[PDF][PDF] Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
JA Nakauma-González, M Rijnders, J Riet… - 2022 - repository.ubn.ru.nl
Recent molecular characterization of primary urothelial carcinoma (UC) may guide future
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
[PDF][PDF] Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
JA Nakauma-Gonzalez… - EUROPEAN …, 2022 - researchinformation.umcutrecht.nl
Recent molecular characterization of primary urothelial carcinoma (UC) may guide future
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma.
JA Nakauma-González, M Rijnders, J van Riet… - European …, 2022 - europepmc.org
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic
Subtypes of Metastatic Urothelial Carcinoma. - Abstract - Europe PMC Sign in | Create an …
Subtypes of Metastatic Urothelial Carcinoma. - Abstract - Europe PMC Sign in | Create an …
Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma
JA Nakauma-González, M Rijnders, J van Riet… - European …, 2022 - research.rug.nl
Recent molecular characterization of primary urothelial carcinoma (UC) may guide future
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …
clinical decision-making. For metastatic UC (mUC), a comprehensive molecular …